Europe Xerostomia Therapeutics Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$575.7

Forecast, 2030 (US$M)

$756.8

CAGR, 2023 - 2030

3.5%

Report Coverage

Europe

Europe xerostomia therapeutics market, 2018-2030 (US$M)

Related Markets

Global Xerostomia Therapeutics Industry

North America Xerostomia Therapeutics Market Outlook

Asia Pacific Xerostomia Therapeutics Market Outlook

Latin America Xerostomia Therapeutics Market Outlook

MEA Xerostomia Therapeutics Market Outlook

Europe xerostomia therapeutics market highlights

The Europe xerostomia therapeutics market generated a revenue of USD 575.7 million in 2022.
The market is expected to grow at a CAGR of 3.5% from 2023 to 2030.
In terms of segment, otc was the largest revenue generating type in 2022.
OTC is the most lucrative type segment registering the fastest growth during the forecast period.

Europe data book summary

Market revenue in 2022	USD 575.7 million
Market revenue in 2030	USD 756.8 million
Growth rate	3.5% (CAGR from 2022 to 2030)
Largest segment	Otc
Fastest growing segment	OTC
Historical data covered	2018 - 2021
Base year for estimation	2022
Forecast period covered	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	OTC
Key market players worldwide	GlaxoSmithKline, Church & Dwight Co Inc, Colgate-Palmolive Co, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceutical Industries, Lupin, Pfizer Inc, Parnell Pharmaceuticals Holdings Ltd, Acacia Pharma

Other key industry trends

In terms of revenue, Europe region accounted for 28.5% of the global xerostomia therapeutics market in 2022.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 570.8 million by 2030.

Key Regions: UK , U.S. , Japan , Brazil , UAE

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Xerostomia Therapeutics Market Scope

Xerostomia therapeutics market segmentation & scope

Type

OTC

Prescription

Product

Salivary Stimulants

Salivary Substitutes

Dentifrices

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

France

Italy

Spain

Denmark

Sweden

Norway

China

Japan

India

Australia

South Korea

Thailand

Brazil

Mexico

Argentina

Saudi Arabia

South Africa

UAE

Kuwait

Xerostomia Therapeutics Market Companies

Name	Profile	# Employees	HQ	Website

Europe xerostomia therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to xerostomia therapeutics market will help companies and investors design strategic landscapes.

Otc was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the Europe xerostomia therapeutics market based on otc covering the revenue growth of each sub-segment from 2018 to 2030.

Reasons to subscribe to Europe xerostomia therapeutics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe xerostomia therapeutics market databook

Our clientele includes a mix of xerostomia therapeutics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe xerostomia therapeutics market, including forecasts for subscribers. This continent databook contains high-level insights into Europe xerostomia therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list